UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey

Journal of clinical oncology, 2001-01, Vol.19 (1), p.205-212

2001

Volltextzugriff (PDF)

Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide

Annals of internal medicine, 2000-10, Vol.133 (7), p.527

2000

Volltextzugriff (PDF)

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

Journal of clinical oncology, 1992-01, Vol.10 (1), p.102-110

1992

Volltextzugriff (PDF)

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

The New England journal of medicine, 1988-09, Vol.319 (10), p.593-598

1988

Volltextzugriff (PDF)

Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature

Annals of hematology, 2004-04, Vol.83 (4), p.242-246

2004

Volltextzugriff (PDF)

Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line

The Journal of biological chemistry, 1993-01, Vol.268 (3), p.2160-2165

1993

Volltextzugriff (PDF)

A Magic Bullet for Cancer — How Near and How Far?

The New England journal of medicine, 2001-07, Vol.345 (4), p.283-284

2001

Volltextzugriff (PDF)

In Vitro and In Vivo Induction of Antiangiogenic Activity by Plasminogen Activators and Captopril

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.388-399

2003

Volltextzugriff (PDF)

Phase I trial of an interleukin‐2 fusion toxin (DAB486IL‐2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy

Cancer, 1994-02, Vol.73 (4), p.1276-1285

1994

Volltextzugriff (PDF)

DNA topoisomerase II α expression is associated with alkylating agent resistance

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (24), p.6109-6116

1995

Volltextzugriff (PDF)

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy

Journal of clinical oncology, 1993-08, Vol.11 (8), p.1583-1591

1993

Volltextzugriff (PDF)

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

Journal of clinical oncology, 1990-04, Vol.8 (4), p.648-656

1990

Volltextzugriff (PDF)

Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells

The Journal of biological chemistry, 1993-07, Vol.268 (19), p.13844-13849

1993

Volltextzugriff (PDF)

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

Antimicrobial Agents and Chemotherapy, 1989-06, Vol.33 (6), p.862-865

1989

Volltextzugriff (PDF)

Resistance of Herpes Simplex Virus to Acycloguanosine: Role of Viral Thymidine Kinase and DNA Polymerase Loci

Proceedings of the National Academy of Sciences - PNAS, 1980-04, Vol.77 (4), p.2270-2273

1980

Volltextzugriff (PDF)

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

Journal of clinical oncology, 1990-07, Vol.8 (7), p.1239-1245

1990

Volltextzugriff (PDF)

A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity

Cancer research (Chicago, Ill.), 1991-01, Vol.51 (2), p.510-513

1991

Volltextzugriff (PDF)

Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo)

Molecular and Cellular Biology, 1992-01, Vol.12 (1), p.198-206

1992

Volltextzugriff (PDF)

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens

Bone marrow transplantation (Basingstoke), 1992-07, Vol.10 (1), p.57

1992

Volltextzugriff (PDF)

SMARCAD1, a Novel Human Helicase Family-Defining Member Associated with Genetic Instability: Cloning, Expression, and Mapping to 4q22–q23, a Band Rich in Breakpoints and Deletion Mutants Involved in Several Human Diseases

Genomics (San Diego, Calif.), 2000-10, Vol.69 (2), p.162-173

2000

Volltextzugriff (PDF)

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

The Journal of clinical investigation, 1987-05, Vol.79 (5), p.1524-1528

1987

Volltextzugriff (PDF)

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir

Antimicrobial Agents and Chemotherapy, 1984-05, Vol.25 (5), p.553-555

1984

Volltextzugriff (PDF)

Winning the War on Cancer

The New England journal of medicine, 1997-09, Vol.337 (13), p.935-938

1997

Volltextzugriff (PDF)

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

Antimicrobial Agents and Chemotherapy, 1979-05, Vol.15 (5), p.642-645

1979

Volltextzugriff (PDF)

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

The New England journal of medicine, 1982-02, Vol.306 (6), p.343-346

1982

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(204)

Sprache

Englisch
(204)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(152)
Humans
(142)
Female
(70)
Biological And Medical Sciences
(64)
Adult
(62)
Male
(60)
Middle Aged
(60)
Oncology
(55)
Medical Sciences
(54)
General & Internal Medicine
(43)
Medicine, General & Internal
(42)
Pharmacology. Drug Treatments
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Antineoplastic Agents
(28)
Aged
(27)
Animals
(26)
Bone Marrow Transplantation
(24)
Cyclophosphamide - Administration & Dosage
(23)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey

Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature

Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line

A Magic Bullet for Cancer — How Near and How Far?

In Vitro and In Vivo Induction of Antiangiogenic Activity by Plasminogen Activators and Captopril

Phase I trial of an interleukin‐2 fusion toxin (DAB486IL‐2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy

DNA topoisomerase II α expression is associated with alkylating agent resistance

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

Resistance of Herpes Simplex Virus to Acycloguanosine: Role of Viral Thymidine Kinase and DNA Polymerase Loci

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity

Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo)

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens

SMARCAD1, a Novel Human Helicase Family-Defining Member Associated with Genetic Instability: Cloning, Expression, and Mapping to 4q22–q23, a Band Rich in Breakpoints and Deletion Mutants Involved in Several Human Diseases

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir

Winning the War on Cancer

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

Suchergebnisse filtern